Thromboangiitis Obliterans: Clinical Trials

1 trial for Thromboangiitis Obliterans, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Not yet recruiting 1

Follow Thromboangiitis Obliterans: new trials by email Literature Review of Thromboangiitis Obliterans trials Research Report on Thromboangiitis Obliterans

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease
BOTOX INJECTION - Buerger Disease, Raynaud Syndrome
Phase 3Not yet recruitingUniversity Hospital, Toulouse82027-01-012026-07-23

Narrower conditions

Raynaud Disease (1)

Broader conditions

Arterial Occlusive Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Embolism and Thrombosis (1)  ·  Livedoid Vasculopathy (1)  ·  Peripheral Vascular Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Vascular (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Thrombosis (1)  ·  Vascular Diseases (1)  ·  Vasculitis (1)

Interventions

Botulinum Toxins (1)

Sponsors

University Hospital, Toulouse (1)

Countries

France (1)

Top investigators

Julie Malloizel-Delaunay, MD (1)